The Effect of Improving Cardiac Function and Quality of Life of Patients with Coronary Heart Disease and Angina Pectoris Using Tongxinluo Capsule
YU Dongjuan
Abstract：Objective: To analyze the effect of Tongxinluo capsules on cardiac function and quality of life in patients with coronary heart disease and angina pectoris. Methods: A total of 80 patients with coronary heart disease and angina pectoris admitted to our hospital from June 2023 to July 2024 were selected as the study subjects and randomly divided into a control group and an observation group, each with 40 cases. The control group was treated with conventional Western medicine, while the observation group received additional treatment with Tongxinluo capsules on top of the control group's regimen. The therapeutic effects of the two groups were compared. Results: The effective rate of the observation group was 97.50%, which was significantly higher than that of the control group at 80.00% (P < 0.05). Before treatment, there was no significant difference in LVEDD, LVESD, and LVEF between the two groups (P > 0.05). After treatment, the LVEDD and LVESD of the observation group were lower than those of the control group, while the LVEF was higher (P < 0.05). After treatment, the scores for physical health, mental health, vitality, and social function in the SF-36 scale of both groups improved compared to before treatment, and the scores of the observation group were higher than those of the control group (P < 0.05). Conclusion: The value of Tongxinluo capsules in treating coronary heart disease and angina pectoris is confirmed, which can improve cardiac function, help patients achieve early rehabilitation, and enhance their quality of life.
Keywords：Coronary heart diseaseAnginaTongxinluo capsulesCardiac functionQuality of life
Publication Date：2025-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 31-33 )